Try our Advanced Search for more refined results
March 26, 2018
Track this case
1:18-cv-02150
Illinois Northern
850(Securities/Commodities)
Honorable Andrea R. Wood
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
Generic-drug maker Akorn Inc. and two of its former executives formally settled with the U.S. Securities and Exchange Commission Monday over false financial statements Akorn made in 2014 that overstated the company's revenue.
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.